ClinicalTrials.gg
SuspendedNCT07343219Updated May 15, 2026

Effects of Root Extract Ashwagandha (KSM-66) on Physiological Stress, Perception of Recovery and Muscle Strength in Youth Footballers

An interventional study of Root extract Ashwagandha and Corn Starch in Performance, Recovery and Strength, sponsored by Sports Performance and Applied Research in Trials and Analysis. Suspended at 1 site in United Kingdom. Open to male participants aged 12 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-15.

Sponsored by Sports Performance and Applied Research in Trials and Analysis · Not applicable, Interventional, and Basic science

How we know

Why this study was suspended
Finalising ethics approval before completing.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
62
Allocation
Randomized
Ages
12 Years to 18 Years
Sex
Male
01

Study summary

This trial examines if six weeks of taking 450 mg Ashwagandha root extract affects exercise performance and recovery in youth male elite football players.

Ashwagandha root extract is increasingly used by athletes, but controlled research in adolescent athletes is limited and the majority of evidence is in an adult population. This study will assess short-term responses in youth players.

Participants will be randomly assigned to take either Ashwagandha root extract or a placebo once daily for six weeks. Players will complete training-based tests, provide saliva samples and complete a short, validated questionnaire on perception of wellness. Any adverse events will be documented and reported.

Read the detailed description

The objective of this trial is to learn whether a short period of taking 450mg of Ashwagandha root extract affects performance, recovery, muscle strength and wellbeing in youth male elite football players.

The researchers are studying Ashwagandha root extract as it is increasingly used by athletes and the general population of varying ages for well-being, performance and recovery purposes, despite a lack of controlled research examining its effects in adolescent athletes. Most existing evidence comes from adult populations, and it remains unclear whether similar physiological and perceptual responses occur in adolescents engaged in structured training.

The main questions the study aims to answer are:

Does taking Ashwagandha root extract change stress levels measured through saliva in youth elite footballers?

Does it affect muscle strength, recovery, sleep, or muscle soreness?

Participants will be randomly assigned to take either Ashwagandha root extract or a placebo once a day for six weeks. During the study, players will complete strength and fitness tests during usual training time, then provide saliva samples afterwards. Short questionnaires will be solicited the day after about how they feel. Any adverse events that occur during the study will be documented and reported.

02

Conditions studied

  • Performance
  • Recovery
  • Strength
  • Aerobic Endurance

Keywords

  • ashwagandha
  • football
  • strength
  • recovery
03

In context

Lead sponsor

Sports Performance and Applied Research in Trials and Analysis is the lead sponsor of 4 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 18 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male youth football player
  • Classified as 'healthy' and 'free of disease'
  • Actively training with the selected football academy

Exclusion criteria

Exclusion Criteria:

  • Lack of signed consent form
  • No active use of medication
  • No active use of ergogenic aids
  • Allergies to nightshades
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
62 participants (actual)

Study arms

  • Experimental
    Ashwagandha root extract

    450 mg Ashwagandha root extract

    Dietary Supplement: Root extract Ashwagandha

  • Placebo comparator
    Placebo

    450 mg corn starch

    Other: Corn Starch

Interventions

  • Dietary supplementRoot extract Ashwagandha

    450 mg Ashwagandha root extract

  • OtherCorn Starch

    450 mg corn starch

06

What researchers measure

Primary outcomes

  1. Change in Salivary Cortisol Concentration from Baseline to 6 Weeks

    Time frame: 6 weeks

Secondary outcomes

  1. Change in Salivary Alpha Amylase from Baseline to 6 Weeks

    Time frame: 6 weeks

  2. Change in Handgrip Strength (kg) from Baseline to 6 Weeks

    Hand grip strength using CAMRY dynamometer

    Time frame: 6 weeks

  3. Change in Countermovement Jump Height (cm) from Baseline to 6 Weeks

    Time frame: 6 weeks

  4. Change in 1 km Time Trial Completion Time (seconds) from Baseline to 6 Weeks

    Maximal effort run of 1km

    Time frame: 6 weeks

  5. Perception of sleep quality

    Sleep quality will be assessed using the sleep domain of the Hooper Index, which is one of four domains within the questionnaire (fatigue, stress, delayed onset muscle soreness, and sleep). The sleep item is rated on a 10-point scale (1 to 10), where 1 indicates very, very good sleep and 10 indicates very, very poor sleep. This domain will be analysed independently as a subset of the Hooper Index, rather than as part of the total score.

    Time frame: Baseline to 6 weeks

  6. Perception of stress

    Perceived stress will be assessed using the sleep domain of the Hooper Index, which is one of four domains within the questionnaire (fatigue, stress, delayed onset muscle soreness and sleep). The stress item is rated on a 10-point scale (1 to 10), where 1 indicates very, very good and 10 indicates very, very poor. This domain will be analysed independently as a subset of the Hooper Index, rather than as part of the total score.

    Time frame: Baseline to 6 weeks

  7. Perception of muscle soreness

    Perceived muscle soreness will be assessed using the sleep domain of the Hooper Index, which is one of four domains within the questionnaire (fatigue, stress, delayed onset muscle soreness and sleep). The muscle soreness item is rated on a 10-point scale (1 to 10), where 1 indicates very, very good and 10 indicates very, very poor. This domain will be analysed independently as a subset of the Hooper Index, rather than as part of the total score.

    Time frame: Baseline to 6 weeks

  8. Perception of fatigue

    Perceived fatigue will be assessed using the sleep domain of the Hooper Index, which is one of four domains within the questionnaire (fatigue, stress, delayed onset muscle soreness and sleep). The fatigue item is rated on a 10-point scale (1 to 10), where 1 indicates very, very good and 10 indicates very, very poor. This domain will be analysed independently as a subset of the Hooper Index, rather than as part of the total score.

    Time frame: Baseline to 6 weeks

  9. Overall Hooper Index Score

    Perceived recovery will be assessed using the Hooper Index, which evaluates four domains: fatigue, stress, delayed onset muscle soreness (DOMS) and sleep quality. Each domain is rated on a 10-point scale (1 to 10), where 1 indicates very, very good and 10 indicates very, very poor. The total Hooper Index score is calculated by summing the four domains, resulting in a possible range of 4 to 40, with higher scores indicating worse perceived recovery, greater fatigue and stress, and lower scores indicating better recovery.

    Time frame: Baseline to 6 weeks

07

Study locations

1 site
  • Strength and Nutrition Ltd
    Brighton, United Kingdom
08

References and documents

Publications

  • Bonilla DA, Moreno Y, Gho C, Petro JL, Odriozola-Martinez A, Kreider RB. Effects of Ashwagandha (Withania somnifera) on Physical Performance: Systematic Review and Bayesian Meta-Analysis. J Funct Morphol Kinesiol. 2021 Feb 11;6(1):20. doi: 10.3390/jfmk6010020. PubMed 33670194 ↗
  • Mishra RK, Trivedi R, Pandya MA. A clinical study of Ashwagandha ghrita and Ashwagandha granules for its Brumhana and Balya effect. Ayu. 2010 Jul;31(3):355-60. doi: 10.4103/0974-8520.77164. PubMed 22131739 ↗
  • Petroczi A, Naughton DP, Pearce G, Bailey R, Bloodworth A, McNamee M. Nutritional supplement use by elite young UK athletes: fallacies of advice regarding efficacy. J Int Soc Sports Nutr. 2008 Dec 15;5:22. doi: 10.1186/1550-2783-5-22. PubMed 19077317 ↗

Individual participant data

Plan to share: Yes — De-identified individual participant data related to primary and secondary outcomes will be shared with other sports nutrition researchers upon reasonable request. Data sharing will be subject to ethical approval, data protection requirements, and safeguarding considerations, and will exclude any information that could identify participants.

Supporting information: Study protocol

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2026 (actual). Primary completion is estimated for Jul 2026, 6 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 6, 2026
First posted
Jan 15, 2026
StartActual
Jan 6, 2026
Primary completionEst.
Jul 17, 2026
CompletionEst.
Jul 18, 2026
Last update
May 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07343219
Lead sponsor
Sports Performance and Applied Research in Trials and Analysis
Responsible party
Sponsor
First posted
Jan 15, 2026
Start date
Jan 6, 2026
Primary completion
Jul 17, 2026 (estimated)
Completion
Jul 18, 2026 (estimated)
Last update
May 15, 2026

Study contacts

Olivia C Coope, PhD
study director · Blanquerna Institute

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is suspended, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion